BSMD: Summary for BioSphere Medical, Inc. - Yahoo! Singapore Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 8:18pm SGT - The Singapore stock market is closed.

To create a watchlist or portfolio of shares, Register

FINANCE HOME PAGE

INVESTING

FINANCE NEWS

BioSphere Medical Inc. (BSMD)

At 4:59AM SGT: 2.68 USD 0.00 (0.00%)

MORE ON BSMD

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BioSphere Medical, Inc. (NGM:BSMD) Delayed quote data

Last Trade:	2.68 USD
Trade Time:	4:59AM SGT
Change:	0.00 (0.00%)
Prev Close:	2.68
Open:	N/A
Bid:	2.36 x 1100
Ask:	3.16 x 200
1y Target Est:	5.00

Day's Range:	N/A - N/A
52wk Range:	1.26 - 4.19
Volume:	0
Avg Vol (3m):	27,381
Market Cap:	48.39M
P/E (ttm):	N/A
EPS (ttm):	-0.25
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Use Y! Toolbar to track stocks

Add BSMD to Portfolio

Download Data

HEADLINES

•	BioSphere Medical Announces Retirement of William M. Cousins, Jr.
	Business Wire (Tue, Feb 2)

•	BioSphere Medical Schedules Fourth Quarter 2009 Financial Results Conference Call February 11
	Business Wire (Fri, Jan 29)

•	BIOSPHERE MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Mon, Jan 11)

•	BioSphere Medical to Present at the 12th Annual Needham Growth Stock Conference
	Business Wire (Thu, Jan 7)

•	BIOSPHERE MEDICAL INC Financials
	EDGAR Online Financials (Wed, Nov 11)

•	BIOSPHERE MEDICAL INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Sat, Nov 7)

•	BioSphere Medical, Inc. Earnings Call scheduled for 8:30 am ET today
	CCBN (Thu, Oct 29)

•	BIOSPHERE MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
	EDGAR Online (Thu, Oct 29)

•	BIOSPHERE MEDICAL INC Files SEC form 8-K, Other Events
	EDGAR Online (Sat, Sep 19)

•	BIOSPHERE MEDICAL INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Aug 14)

More Headlines for BSMD...

ANALYST

EPS Est (next year) (Dec-09) :	-0.21
EPS Est (in 2 years) (Dec-10) :	-0.21
Avg Rec (current)*:	1.5
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

BioSphere Medical, Inc. develops, manufactures, and markets products for medical procedures that use embolotherapy. The company focuses on the treatment of symptomatic uterine fibroids, which are noncancerous, or benign, hypervascular tumors growi...

Full Company Profile

Add to Portfolio

Email to a Friend

•